1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Patrys Limited
  6. News
  7. Most relevant
    PAB   AU000000PAB9

PATRYS LIMITED

(PAB)
Delayed Australian Stock Exchange  -  01:44 2022-08-11 am EDT
0.0260 AUD    0.00%
08/10Patrys Validates Efficacy of Brain Cancer Drug in Preclinical Animal Study
MT
08/07Patrys Chair to Retire End-August
MT
07/27PATRYS : Appendix 4C - Quarterly - 30 June 2022
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PATRYS LIMITED
08/10Patrys Validates Efficacy of Brain Cancer Drug in Preclinical Animal Study
MT
08/09Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1
CI
08/07Patrys Chair to Retire End-August
MT
07/27PATRYS : Appendix 4C - Quarterly - 30 June 2022
PU
07/04Patrys Produces Antibody Drug at Commercial Scale
MT
07/03Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run
CI
06/14Patrys Identifies New Mechanism of Action for Anti-Cancer Antibody
MT
06/03Patrys Secures Grant Funding to Develop Brain Cancer Drug
MT
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
04/14PATRYS : Application for quotation of securities - PAB
PU
03/23NEW RESEARCH : Scientists determine structure of a DNA damage ‘First Responder' prot..
PU
02/27Patrys Limited Announces Stable Cell Line for Production of PAT-DX3
CI
02/24PATRYS : Appendix 4D - Half Year Accounts - 31 December 2021
PU
02/24Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2021
CI
02/07PATRYS : Application for quotation of securities - PAB
PU
02/07PATRYS : ADC Deals Making Headlines
PU
01/30PATRYS : Appendix 4C - Quarterly - 31 December 2021
PU
01/23Patrys' Subsidiary Secures R&D Tax Refund for FY21; Shares Tumble 27%
MT
2021PATRYS : Ceasing to be a substantial holder from MQG
PU
2021PATRYS : Application for quotation of securities - PAB
PU
2021PATRYS : Change of Director's Interest Notices x2
PU
2021PATRYS : Application for quotation of securities - PAB
PU
2021PATRYS : Notification regarding unquoted securities - PAB
PU
2021PATRYS : Notification regarding unquoted securities - PAB
PU
2021Becoming a substantial holder from MQG
PU
2021Rights Issue Offer Document
PU
2021PATRYS LIMITED : RIGHTS ISSUE: 1 new share @ 0.035 AUD for 12 existing shares
FA
2021Patrys Limited announced that it expects to receive AUD 2.5 million in funding
CI
2021Patrys Limited Announces Executive Changes
CI
2021PATRYS' : Deoxymab Antibody Drug Increases Survival Chances in Animal Models of Breast Can..
MT
2021Patrys Limited Announces Data from Its Completed Preclinical Study of Deoxymab Antibody..
CI
2021Patrys Limited Demonstrates Potential for Deoxymabs in Antibody Drug Conjugates
CI
2021Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
2021PATRYS : Postpones PAT-DX1 Clinical Trial over Disruption in Global Supply Chains
MT
2021Patrys Limited Provides This Interim Update on Its PAT-DX1 Clinical Trial Program
CI
2021PATRYS' : Drug Improves Pancreatic Cancer Survival in Animal Study
MT
2021Patrys Limited Announces Preclinical Study in Model of Pancreatic Cancer
CI
2021Patrys Limited Announces Full Size Deoxymab PAT-DX3 Able to Cross the Blood Brain Barri..
CI
2021PATRYS LIMITED : Announces Publication of PAT-DX1 Preclinical Data in JCI - Insight
BU
2021PATRYS' : Deoxymab Antibody May Hinder Growth of Brain Cancers, Metastases
MT
2021Patrys Limited Announces the Publication of New Preclinical Data for Its Deoxymab Antib..
CI
2021PATRYS : Receives More than $480,000 R&D Tax Refund; Shares Up 3%
MT
2021PATRYS : Imagion Biosystems to Collaborate on Brain Tumor Imaging and Diagnosis Product; S..
MT
2021Imagion Biosystems Limited and Patrys Limited Collaborate on New Cancer Imaging Agents
CI
2021Patrys Completes PAT-DX1 and Pat-DX3 Pharmacokinetic Studies
CI
2021Australian Shares Rebound as Country's Total Credit, Dwellings Approvals Rise
MT
2021PATRYS : Secures US Patent for Anti-Cancer Treatment Deoxymab; Shares Jump 7%
MT
2021Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2020
CI
2021Patrys Limited Successfully Establishes PAT-DX1 Stable Cell Line
CI
2020PATRYS LIMITED : RIGHTS ISSUE: 1 new share @ 0.02 AUD for 6 existing shares
FA
2020PATRYS : Adds Full Human Antibody to Deoxymab Portfolio
PU
2020PATRYS : Adds Full Human Antibody to Deoxymab Portfolio
PU
2020Patrys Limited Adds Full Human Antibody to Deoxymab Portfolio
CI
2020Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2020
CI
2020PATRYS : Entitlement Offer Results and Shortfall Notification
PU
2020PATRYS LIMITED : RIGHTS ISSUE: 1 new share @ 0.012 AUD for 3 existing shares
FA
2020PATRYS : New Appointment to Scientific Advisory Board
PU
2020Patrys Limited Appoints Peter Ordentlich to Its Scientific Advisory Board
CI
2020Patrys Limited Announces New Pre-Clinical Data for Its Lead Candidate, Pat-Dx1
CI
2020Patrys Limited Announces New Pre-Clinical Animal Data for Its Development Asset Pat-Dx1..
CI
2020Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2019
CI
2019Patrys Limited Announces Appointment of Dr. Pamela M. Klein as Non-Executive Director
CI
2019PATRYS : Annual Report 2019
PU
2019Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2019
CI
2019PATRYS : Presented at Leading Brain Metastases Conference
PU
2019PATRYS : Updated Investor Presentation and Attendance at Bioshares
PU
2019PATRYS : PAT-DX1 Significantly Improves Survival in Aggressive GBM
PU
2019Patrys Limited Announces PAT-DX1 Significantly Improves Survival in an Animal Model of ..
CI
2019PATRYS : Europe Grants Patent for Deoxymab 3E10
PU
2019Patrys Limited Announces PAT-DX1 Reduces Brain Metastases, Enhances Radiation Therapy
CI
2019PATRYS : Presentation at AACR Conference
PU
2019Patrys Limited Announces Consolidated Earnings Results for the Half-Year Ended 31 Decem..
CI
2019PATRYS : Presenting at Biotech Showcase
PU
2019PATRYS : Receives R&D Tax Incentive Refund
PU
2018PATRYS : PAT-DX1 Suppresses Breast Cancer Brain Metastases
PU
1  2  3Next
Upcoming event on PATRYS LIMITED